Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
21.77%
Operating Margin
13.78%
Net Margin
9.81%
Efficiency Metrics
Revenue per Expense Ratio
1.16
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
20.32%
Income Tax Rate
24.54%
EPS
8.4100000000
Balance Sheet Analysis
Current Ratio
2.57
Cash Ratio
0.90
Working Capital
$1.99B
Debt to Equity
0.79
Debt to Assets
36.55%
Equity Ratio
46.05%
Cash Flow Analysis
Operating Cash Flow Ratio
16.86%
Free Cash Flow Ratio
10.80%
CapEx to Revenue
6.05%
Dividends Paid
$448.90M
Stock Buybacks
$41.50M
Total Shareholder Returns
$490.40M
Cash Position Change
102.50%
Key Takeaways (2023 FY)
Revenue declined by 7.9688605803255%, indicating potential market challenges
Increased dividend payments by 10.64%
Detailed Growth Metrics
Core Performance
Revenue
-7.97%
Net Income
-25.69%
EPS
-23.04%
Operating Income
9.88%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-4.55%
Operating Cash Flow
-12.03%
Free Cash Flow
26.03%
Balance Sheet Health
Assets
8.46%
Debt
13.61%
Book Value per Share
12.92%
Inventory
3.66%
Shareholder Returns
Dividends per Share
10.64%
Shares Outstanding
-3.47%
Long Term Trends
3Y Revenue/Share
23.76%
5Y Revenue/Share
16.90%
3Y Dividend/Share
58.24%
5Y Dividend/Share
75.98%